Carcinoma of the oropharynx: Local failure as the decisive parameter for distant metastases and survival

Strahlentherapie und Onkologie

Volumn 176, Issue 1, 2000, Pages 16-21

  Beer, Karl T ^a   Greiner, Richard H ^a,b   Aebersold, Daniel M ^a   Zbären, Peter ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Clinical parameters; Local control; Metastases; Oropharynx carcinoma; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NECK DISSECTION; OROPHARYNX CARCINOMA; PREDICTION; PROGNOSIS; TREATMENT FAILURE;

EID: 0033985656     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002299     Document Type: Article

References (25)

1. Al-Sarraf M. LeBlanc M. Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 1998;16:1310-7.
2. Bataini JP, Asselain B, Jaulerry C, et al. A multivariate primary tumor control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: Clinical and treatment parameters as prognostic factors. Radiother Oncol 1989;14:265-77.
3. Baumann M, Bentzen SM, Ang KK. Hyperfractionated radiotherapy in head and neck cancer: a second look at the clinical data, adiother Oncol 1998;46:127-30.
4. Beck-Bornholdt HP, Dubben HH, Liertz-Petersen C. et al. Hyperfractionation: where do we stand? Radiother Oncol 1997;43:1-21.
5. Beer KT, von Briel C, Lampret T, et al. Prädiktive Bedeutung der Reflex-Otalgie in der radikalen Radiotherapie von Oropharynxkarzinomen. Strahlenther Onkol 1998;174:306-10.
6. Bentzen S, Johansen LV. Overgaard J, et al. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991;20:1197-206.
7. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherpay for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-804.
8. Dische S, Saunders MI, Barrett A, et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-36.
9. Fietkau R, Iro H, Grabenbauer GG, et al. Simultane Radio-Chemothera-pie mit Cisplatin und 5-FU bei fortgeschrittenen Kopf-Halstumoren. Strahlenther Onkol 1991;167:693-700.
10. Freeman DE, Mendall WM, Parsons JT. et al. Does neck stage influence local control in squamous cell carcinomas of the head and neck? Int J Radiat Oncol Biol Phys 1992;23:733-6.
11. Greiner RH, Brutschin P, Teixera W. Epipharynxkarzinom: Kriterien lokaler Tumorfreiheit und Heilung nach perkutaner Strahlentherapie. In: Wannenmacher M, Hrsg. Nasopharynx-Tumoren. Sonderbände zur Strahlentherapie. Bd 78. München-Wien-Baltimore: Urban & Schwarzenberg, 1984;49-57.
12. Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomised trial. Radiother Oncol 1997;44: 111-21.
13. Huguenin P, Glanzmann C, Taussky D, et al. Hyperfractionated radiotherapy and simultaneous cisplatin for Stage III and IV carcinomas of the head and neck. Strahlenther Onkol 1998;174:397-102.
14. Jeremic B, Shibamoto Y, Stanisavljevic S, et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol 1997;43:29-37.
15. Leibel SA, Scott CB, Mohiuddin M, et al. The effect of local-regional control on distant metastastic dissemination in carcinom of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991;21:549-56.
16. Lewin F, Damber L, Jonsson H, et al. Neoadjuvant chemotherapy with cisplatin and 5-fluoro-uracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III trial. Radiother Oncol 1997;43: 23-8.
17. Merlano M, Benasso M, CorvÚ R, et al. Five year up-date of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. Natl Cancer Inst 1996;88:583-9.
18. Pinto LHJ, Canary PCV, Arraujo CMM, et al. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oro-pharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:557-62.
19. Regueiro CA, Aragon G, Millan I, et al. Prognostic factors for local control and survival in oropharyngeal squamous cell carcinoma. Eur J Cancer 1994;30:2060-7.
20. Stuschke M, Thames HD. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 1991;21:557-62.
21. Stuschke M, Thames HD. Hyperfractionated: where do we stand? Radiother Oncol 1998;46:131-3.
22. Teo PM, Chan AT, Lee WY, et al. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. Int J Radiat Oncol Biol Phys 1999;43:261-71.
23. Wendt TG, Wustrow TPU, Schalhorn A. Ergebnissse der simultanen Radio-Chemotherapie bei fortgeschrittenen Kopf-Hals-Tumoren. Strahlenther Onkol 1990;166:569-79.
24. Wendt TG, Grabenbauer GG, Rödel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head: a randomized multicentre study. J Clin Oncol 1998:16:1318-24.
25. Zbären P, Lehmann W. Frequency and sites of distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1987;13:762-4.